Bain Capital Life Sciences Investors, LLC Q4 2018 Filing

Filed February 14, 2019

Portfolio Value

$292.6B

Holdings

6

Report Date

Q4 2018

Filing Type

13F-HR

All Holdings (6 positions)

#StockSharesValue% PortfolioType
1
—DICERNA PHARMACEUTICALS INC
8,930,237$95.5B32.62%
2
IFRXINFLARX NV
1,764,888$64.2B21.93%
3
SLDBSOLID BIOSCIENCES INC
1,989,444$53.3B18.22%
4
—APTINYX INC
2,225,092$36.8B12.58%
5
REPLREPLIMUNE GROUP INC
2,838,968$28.4B9.70%
6
—MARINUS PHARMACEUTICALS INC
5,042,735$14.5B4.95%